About 200 reports

  • CHRONIC PAIN
  • 3.2.2.2. CHRONIC PAIN AND MENTAL HEALTH

CHRONIC PAIN AND MENTAL HEALTH ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##.

  • Chronic Pain
  • North America
  • United States
  • Eli Lilly & Co.
  • Grunenthal GmbH

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • Market Shares
  • Market Size

Chronic Neuropathic Pain KOL Survey Biomedtracker performed a ##-question survey of ## United States neurologists who currently treat patients with chronic neuropathic pain and prescribe opioids to at least some of their patients with chronic neuropathic

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • United States

Opioids are considered one of the most effective drug classes for the treatment of chronic pain.

  • Chronic Disease
  • Chronic Pain
  • North America
  • World
  • Market Size
  • shows the etiology of chronic pain.
  • shows the classification of pain, including family and subfamily.

Tsuda, M. et al. (2013) ' Microglia and intractable chronic pain', Glia, ##(##), pp. ##-##. doi: ##. ##/ glia. ##.

  • Chronic Pain
  • United States
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • U.S. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
  • 10.9.4 KEY DEVELOPMENTS

ACCORDING TO PAIN ALLIANCE EUROPE, ONE OUT OF FIVE EUROPEANS ARE SUFFERING FROM CHRONIC PAIN AND IT CONSIDERED AS ONE OF THE MAIN CAUSES OF DISABILITY, WITH CONSIDERABLE NEGATIVE EFFECTS ON PRODUCTIVITY AT WORK.

  • Chronic Pain
  • World
  • Market Size
  • Medtronic, Inc.
  • Stryker Corporation

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Japan
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • United States
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • United Kingdom
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Italy
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Germany
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • France
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Spain
  • Market Shares
  • Market Size

Lower back pain is one of the most predominant types of chronic pain.

  • Chronic Pain
  • APAC
  • Europe
  • World
  • Market Shares

It causes joints to swell and can result in pain, stiffness, and progressive loss of function.

  • Chronic Pain
  • World
  • Amgen Inc.
  • Antares Pharma, Inc.
  • Bayer AG
  • 2.1 Preface
  • JIANGSU HENGRUI MEDICINE

Rating indicates the level of growth opportunities and the green arrows point to the category with high opportunities Impact: ## High Cymbalta is indicated for the treatment of the major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromy

  • Chronic Pain
  • Depomed, Inc.
  • Eli Lilly & Co.
  • Endo International plc
  • Pfizer Inc.

Acute Pain- Epidemiology Forecast-2028 ##.

  • Chronic Pain
  • Germany
  • Spain
  • United Kingdom
  • United States

This procedure reduces the pain and also increases the joint mobility.

  • Chronic Pain
  • World
  • Forecast
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation

Replacements of hip and knee joints are carried out in patients suffering from chronic pain and poor functioning of hip and knee joints.

  • Chronic Pain
  • World
  • Market Segment
  • Smith & Nephew Plc
  • Stryker Corporation
  • Osteoarthritis Nutrition & Food Supplement Market: Revenue in USD million, Italy, 2015-2025
  • MARKET DYNAMICS

MARKET DYNAMICS DRIVERS INCREASING INCIDENCE OF OSTEOARTHRITIS Osteoarthritis is the most prevalent type of joint disease and also a leading cause of chronic pain and disability in the United States.

  • Chronic Pain
  • North America
  • United States
  • World
  • Koninklijke DSM N.V.

Acute pain is distinct from chronic pain and is relatively more sharp and severe.

  • Chronic Disease
  • Chronic Pain
  • Therapy
  • United States
  • Market Size

Neuropathic Pain Market and Forecast Analysis to 2024 TABLE OF CONTENTS ## TREATMENT: NEUROPATHIC PAIN (Published on ## March 2018) ## OVERVIEW ## EXECUTIVE SUMMARY ## PRIMARY RESEARCH METHODOLOGY ## DISEASE DEFINITION AND DIAGNOSIS ## PATIENT SEGMENTATION ## CURRENT TREATMENT OPTIONS

  • Chronic Disease
  • Chronic Pain
  • European Union
  • Japan
  • United States

This procedure reduces the pain and also increases the joint mobility.

  • Chronic Pain
  • World
  • Forecast
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation

Whereas, the back braces are generally used for erection of spine and various others factors such as osteoarthritis of the facet joints, chronic back pain, and backache.

  • Chronic Pain
  • World
  • Forecast
  • Market Size
  • Bauerfeind AG
  • Executive summary
  • Key takeaways

In non-malignant pain, the indications include failed back syndrome; spinal stenosis; arachnoiditis; complex regional pain syndrome Type ## and Type ##; chronic pancreatitis; pelvic pain syndrome; fracture of cervical, thoracic, or lumbar vertebrae; and

  • Chronic Pain
  • Market Size
  • Flowonix Medical, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated
  • Market drivers
  • Key vendor analysis

Although back support products offered by most vendors have low product differentiation, choosing back support for chronic pain requires detailed specifications as one back support cannot be used for all types of chronic pain in the middle, lower, upper b

  • Chronic Pain
  • Musculoskeletal Disorder
  • World
  • Demand
  • DeRoyal Industries, Inc.

Neuropathic Pain Market and Forecast Analysis to 2026 CONTENTS ## FORECAST: NEUROPATHIC PAIN (Published on ## May 2018) ## OVERVIEW ## MARKET DYNAMICS ## FORECAST AND FUTURE TRENDS ## MARKET DEFINITION AND METHODOLOGY ## PRIMARY RESEARCH METHODOLOGY ## BIBLIOGRAPHY ## PRODU

  • Chronic Disease
  • Chronic Pain
  • European Union
  • Japan
  • United States
  • APPROVED PHARMACOLOGICAL TREATMENT DRUGS FOR CHRONIC PAIN
  • DRUGS UNDER DEVELOPMENT FOR SEVERE CHRONIC PAIN

Acute pain activates one or more types of peripheral pain receptors, known as nociceptors.

  • Chronic Pain
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • MARKET SEGMENTATION- NORTH AMERICA

In Mexico, PRP platelet-rich plasma treatment is used to benefit people suffering from chronic pain in the lower back, spinal stenosis, rotator cuff tear, arthritis of the knee, and achilles tendinosis.

  • Chronic Pain
  • Arthrex, Inc.
  • DePuy Orthopaedics, Inc.
  • EmCyte Corporation
  • Synthes, Inc.